As a global leader in HPV vaccination and cervical cancer prevention, Jhpiego works with countries to introduce and expand HPV vaccination and explore new ways to integrate HPV vaccinations into other health services for adolescents. We’re excited to share our latest research and learnings at the 38th Annual International Papillomavirus Society (IPVS) Conference and to contribute to the global conversation on HPV vaccination and cervical cancer prevention.
Sustaining HPV Vaccination Within Routine Immunization Systems: Evidence From Real-World Implementation
October 23 | 18:30 - 19:30 | MC2 Hall
A CHIC Event in collaboration with University of Antwerp and the London School of Hygiene and Tropical Medicine.
Results from the Gavi Commissioned HPV Implementation Research Portfolio on Integrating HPV Vaccination with other Adolescent Services
October 24 | 17:30 - 19:00 | MC2/3
Side event in collaboration with Gavi, the Vaccine Alliance.
Cervical Cancer Elimination Lab: Accelerating 90–70–90 Under Real-World Constraints
October 24 | 8:00 - 9:00 | MC2 Hall
In collaboration with Unitaid and Gavi, the Vaccine Alliance.
Cross-Cutting Lessons Learned Across a Multi-Country HPV-Adolescent Health Integration Implementation Research Portfolio
Delivery Strategies and Their Impact on HPV Vaccination Coverage: A Global Descriptive Analysis
Does Leveraging Adolescent Health Programs for Integrated Delivery Approaches To HPV Vaccination Have A “Pro-Equity” Effect For Vulnerable Under-Served Adolescents?
Global Progress Toward the Who 2030 HPV Vaccination Target: A Time-Series Analysis Of 116 Countries
Sustained Multilevel Engagement and Collaboration to Strengthen HPV Vaccination Programming: Insights from Two Counties in Kenya
